These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 32402997

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin.
    Lau YC, Xiong Q, Lip GY, Blann AD.
    Ann Med; 2016; 48(4):275-81. PubMed ID: 27043881
    [Abstract] [Full Text] [Related]

  • 7. The mechanism of action of rivaroxaban--an oral, direct Factor Xa inhibitor--compared with other anticoagulants.
    Samama MM.
    Thromb Res; 2011 Jun; 127(6):497-504. PubMed ID: 20888031
    [Abstract] [Full Text] [Related]

  • 8. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets.
    Schols SE, Feijge MA, Lancé MD, Hamulyák K, ten Cate H, Heemskerk JW, van Pampus EC.
    Transfusion; 2008 Nov; 48(11):2384-94. PubMed ID: 18673348
    [Abstract] [Full Text] [Related]

  • 9. Anticoagulant activity of original synthetic peptide derivatives.
    Drozd NN, Tolstenkov AS, Makarov VA, Miphtakhova NT, Voyushina TL, Sergeev ME.
    Bull Exp Biol Med; 2008 Jan; 145(1):51-4. PubMed ID: 19024001
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enhanced anticoagulant activity of enoxaparin in patients with ESRD as measured by thrombin generation time.
    Brophy DF, Martin EJ, Gehr TW, Carr ME.
    Am J Kidney Dis; 2004 Aug; 44(2):270-7. PubMed ID: 15264185
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cystamine preparations exhibit anticoagulant activity.
    Aleman MM, Holle LA, Stember KG, Devette CI, Monroe DM, Wolberg AS.
    PLoS One; 2015 Aug; 10(4):e0124448. PubMed ID: 25915545
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Simultaneous assessment of DOACs effect on clot formation and fibrinolysis with the FibWave.
    Evrard J, Maloteau V, Dogné JM, Douxfils J.
    Int J Lab Hematol; 2022 Apr; 44(2):e79-e83. PubMed ID: 34613661
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.